الفهرس 
Chronic Kidney disease and Renal Replacement therapyOnly 14 pages are availabe for public view
 |  | from | 248 |  |  |
| | | from | 248 | | |
Abstract
Renal transplantation is the best form of renal replacement
therapy for patients with end stage renal disease (ESRD), in
comparison to dialysis, as it is associated with higher patient
survivals, lower hospitalization rate and a superior quality of
life.
Hepatitis C virus infection is an important consideration in
kidney transplantation candidates and graft recipients. Mortality
rates are higher among kidney transplant recipients who are
positive for HCV antibodies (anti-HCV), have higher rates of
liver complications and have lower survival rates after
transplantation than anti-HCV–negative recipients.
HCV-positive renal allograft recipients have lower graft
survival duration and higher rate of infections when compared
with HCV-negative renal transplant patients.
NKT cells represent a heterogeneous group of
immunoregulatory and effector cells, which express both NK
and T-cell markers. They may protect against infection through
their cytolytic activity by producing cytokines or via
stimulation of other cell populations
So, the aim of the present study is to assess the possible
effect of HCV infection on the level of the peripheral blood NK
CD 3+ and CD16+ in renal allograft recipients and their
association with intercurrent infection.